{
  "id": "609e95627188ec94",
  "title": "RBC Capital Bullish on ADC Therapeutics S . A . ( ADCT ) on Lymphoma Treatment Development",
  "description": "20251218T071500Z",
  "content": "",
  "source": "insidermonkey.com",
  "source_url": "https://www.insidermonkey.com/blog/rbc-capital-bullish-on-adc-therapeutics-s-a-adct-on-lymphoma-treatment-development-1661271/",
  "published_at": "20251218T071500Z",
  "fetched_at": "2025-12-19T00:23:08.544189+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [],
  "location": "United States",
  "raw_data": {
    "url": "https://www.insidermonkey.com/blog/rbc-capital-bullish-on-adc-therapeutics-s-a-adct-on-lymphoma-treatment-development-1661271/",
    "url_mobile": "https://www.insidermonkey.com/blog/rbc-capital-bullish-on-adc-therapeutics-s-a-adct-on-lymphoma-treatment-development-1661271/?amp=1",
    "title": "RBC Capital Bullish on ADC Therapeutics S . A . ( ADCT ) on Lymphoma Treatment Development",
    "seendate": "20251218T071500Z",
    "socialimage": "https://d2gr5kl7dt2z3t.cloudfront.net/blog/wp-content/uploads/2025/10/25031938/pexels-dubart-6608503.jpg",
    "domain": "insidermonkey.com",
    "language": "English",
    "sourcecountry": "United States"
  }
}